Pemetrexed-Based Chemotherapy Is Inferior to Pemetrexed-Free Regimens in Thyroid Transcription Factor 1 (TTF-1)-Negative, EGFR/ALK-Negative Lung Adenocarcinoma: A Propensity Score Matched Pairs Analysis

JOURNAL ARTICLE published November 2020 in Clinical Lung Cancer

Authors: Nikolaj Frost | Tamar Zhamurashvili | Maximilian von Laffert | Frederick Klauschen | Christoph Ruwwe-Glösenkamp | Matthias Raspe | Matthias Brunn | Sebastian Ochsenreither | Bettina Temmesfeld-Wollbrück | Norbert Suttorp | Christian Grohé | Martin Witzenrath